198 related articles for article (PubMed ID: 10092690)
1. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.
Guite HF; Dundas R; Burney PG
Thorax; 1999 Apr; 54(4):301-7. PubMed ID: 10092690
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease.
Sin DD; Tu JV
Thorax; 2000 Mar; 55(3):194-7. PubMed ID: 10679537
[TBL] [Abstract][Full Text] [Related]
3. Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
Meier CR; Jick H
Thorax; 1997 Jul; 52(7):612-7. PubMed ID: 9246132
[TBL] [Abstract][Full Text] [Related]
4. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
Lee TA; Pickard AS; Au DH; Bartle B; Weiss KB
Ann Intern Med; 2008 Sep; 149(6):380-90. PubMed ID: 18794557
[TBL] [Abstract][Full Text] [Related]
5. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
Ringbaek T; Viskum K
Respir Med; 2003 Mar; 97(3):264-72. PubMed ID: 12645834
[TBL] [Abstract][Full Text] [Related]
6. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
Rodrigo GJ; Rodrigo C
Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
[TBL] [Abstract][Full Text] [Related]
7. Ipratropium treatment of acute airways disease.
Peterson GM; Boyles PJ; Bleasel MD; Vial JH
Ann Pharmacother; 2003 Mar; 37(3):339-44. PubMed ID: 12639159
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroids and mortality in COPD.
Macie C; Wooldrage K; Manfreda J; Anthonisen NR
Chest; 2006 Sep; 130(3):640-6. PubMed ID: 16963657
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
11. Risk of arrhythmias associated with ipratropium bromide in children, adolescents, and young adults with asthma: a nested case-control study.
Adimadhyam S; Schumock GT; Walton S; Joo M; McKell J; Lee TA
Pharmacotherapy; 2014; 34(4):315-23. PubMed ID: 23918239
[TBL] [Abstract][Full Text] [Related]
12. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
13. Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: a population-based nested case-control study.
Wang MT; Tsai CL; Lo YW; Liou JT; Lee WJ; Lai IC
Int J Cardiol; 2012 Jul; 158(2):279-84. PubMed ID: 22386700
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.
van Noord JA; Bantje TA; Eland ME; Korducki L; Cornelissen PJ
Thorax; 2000 Apr; 55(4):289-94. PubMed ID: 10722768
[TBL] [Abstract][Full Text] [Related]
15. Mortality in Asthma-Chronic Obstructive Pulmonary Disease Overlap in the United States.
Kumbhare S; Strange C
South Med J; 2018 May; 111(5):293-298. PubMed ID: 29767222
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events associated with ipratropium bromide in COPD.
Ogale SS; Lee TA; Au DH; Boudreau DM; Sullivan SD
Chest; 2010 Jan; 137(1):13-9. PubMed ID: 19363211
[TBL] [Abstract][Full Text] [Related]
17. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group.
Kerstjens HA; Brand PL; de Jong PM; Koëter GH; Postma DS
Thorax; 1994 Nov; 49(11):1109-15. PubMed ID: 7831626
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of tiotropium and ipratropium in prevention of hospital readmission for COPD: a population-based cohort study.
Kawasumi Y; Paterson MJ; Morrow RL; Miller TA; Bassett K; Wright JM; Dormuth CR
Clin Ther; 2013 Apr; 35(4):523-531.e1. PubMed ID: 23490290
[TBL] [Abstract][Full Text] [Related]
19. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
Griffiths B; Ducharme FM
Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
[TBL] [Abstract][Full Text] [Related]
20. Ipratropium bromide in acute asthma.
Ward MJ; Fentem PH; Smith WH; Davies D
Br Med J (Clin Res Ed); 1981 Feb; 282(6264):598-600. PubMed ID: 6451257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
